for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Asahi Kasei Corp

3407.T

Latest Trade

851.90JPY

Change

-19.60(-2.25%)

Volume

2,723,900

Today's Range

849.50

 - 

866.70

52 Week Range

606.10

 - 

1,295.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
871.50
Open
862.50
Volume
2,723,900
3M AVG Volume
125.66
Today's High
866.70
Today's Low
849.50
52 Week High
1,295.00
52 Week Low
606.10
Shares Out (MIL)
1,387.49
Market Cap (MIL)
1,214,812.00
Forward P/E
13.98
Dividend (Yield %)
3.90

Next Event

Q1 2021 Asahi Kasei Corp Earnings Release

Latest Developments

More

Adient Enters Into Agreement To Sell Its Fabrics Business For $175 Mln

Veloxis: Asahi Kasei Pharma Denmark Announces Preliminary Result Of Its Public Tender Offer For Shares And Warrants In Co

Competition Approvals Obtained For Asahi Kasei Pharma Denmark Offer For Veloxis Pharmaceuticals

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Asahi Kasei Corp

ASAHI KASEI CORPORATION is mainly engaged in material business, housing business and others. The Company operates in three business segments. The Materials segment includes fiber business, including capra fiber, polyurethane fiber, nonwoven fabric, nylon 66 fiber, chemical business, including petrochemicals, high performance polymer, high performance materials and consumer goods, separators for lithium secondary batteries, separators for lead storage batteries, mixed signal LSI and other electronic businesses. The Housing segment includes housing business, such as construction contracting, real estate, renovation, and other housing related businesses, and the building materials business, including lightweight aerated concrete, heat insulation materials, foundation piles, structural materials. The Healthcare segment consists of pharmaceuticals such as medical drugs and diagnostics, medical business and critical care business. It also includes engineering, staffing business and others.

Industry

Chemical Manufacturing

Contact Info

Hibiya Mitsui Tower, 1-1-2, Yuraku-cho

CHIYODA-KU, TKY

100-0006

Japan

+81.3.66993000

https://www.asahi-kasei.co.jp/

Executive Leadership

Hideki Kobori

Executive President, President, Representative Director

Yutaka Shibata

Executive Vice President, Director

Shigeki Takayama

Executive Vice President, Representative Director

Hiroshi Yoshida

Executive Vice President, Director

Fumitoshi Kawabata

Senior Managing Executive Officer, President of Subsidiary, Director

Key Stats

2.92 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2018

2.0K

2019

2.2K

2020

2.2K

2021(E)

2.0K
EPS (JPY)

2018

121.930

2019

105.660

2020

74.850

2021(E)

60.244
Price To Earnings (TTM)
11.64
Price To Sales (TTM)
0.56
Price To Book (MRQ)
0.89
Price To Cash Flow (TTM)
5.42
Total Debt To Equity (MRQ)
52.11
LT Debt To Equity (MRQ)
21.53
Return on Investment (TTM)
5.56
Return on Equity (TTM)
3.94

Latest News

Latest News

Asahi Kasei makes $1.3 billion offer for Denmark's Veloxis

Asahi Kasei <3407.T> has offered 8.9 billion Danish crowns ($1.31 billion) to buy Veloxis <VELOX.CO>, it said on Monday, a deal that would give the Japanese electronic materials maker access to the U.S. pharmaceutical market.

CORRECTED-Asahi Kasei makes $1.3 bln offer for Denmark's Veloxis

Japan's Asahi Kasei Corp on Monday said it had offered to take full ownership of Danish pharmaceutical company Veloxis for 8.9 billion Danish crowns ($1.31 billion).

BRIEF-Asahi Kasei's Group Operating Profit Seen Climbing 20% To Around 190 Bln Yen - Nikkei

* ASAHI KASEI CORP'S GROUP OPERATING PROFIT IS SEEN CLIMBING 20 PERCENT TO AROUND 190 BILLION YEN IN THE FISCAL YEAR ENDING MARCH 31 - NIKKEI

Asahi Kasei unit wins $400 million U.S. defense contract -Pentagon

Zoll Medical Corp, a unit of Asahi Kasei Corp, has been awarded a $400 million contract for deployable vital signs monitors, the Pentagon said on Friday. (Reporting by Mohammad Zargham; Editing by Eric Beech)

BRIEF-Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan

* REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up